ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS · IEX Real-Time Price · USD
0.206
-0.006 (-2.79%)
Jul 22, 2024, 10:09 AM EDT - Market open
ReShape Lifesciences Employees
ReShape Lifesciences had 29 employees as of December 31, 2023. The number of employees decreased by 11 or -27.50% compared to the previous year.
Employees
29
Change (1Y)
-11
Growth (1Y)
-27.50%
Revenue / Employee
$287,414
Profits / Employee
-$376,483
Market Cap
6.04M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
CareMax | 1,450 |
Telesis Bio | 147 |
Soligenix | 15 |
Pasithea Therapeutics | 8 |
Tenax Therapeutics | 6 |
Xenetic Biosciences | 4 |
GT Biopharma | 2 |
RSLS News
- 3 days ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHUY, RSLS on Behalf of Shareholders - GlobeNewsWire
- 5 days ago - RESHAPE LIFESCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ReShape Lifesciences Inc. - RSLS - Business Wire
- 7 days ago - RSLS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of ReShape Lifesciences Inc. Is Fair to Shareholders - Business Wire
- 12 days ago - Vyome to go public and trade on the Nasdaq Capital Market under the ticker symbol “HIND” - GlobeNewsWire
- 13 days ago - ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys - GlobeNewsWire
- 2 months ago - ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update - GlobeNewsWire
- 3 months ago - ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update - GlobeNewsWire